Ensysce Biosciences Inc (NASDAQ: ENSC) is -40.03% lower on its value in year-to-date trading and has touched a low of $0.14 and a high of $2.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ENSC stock was last observed hovering at around $0.71 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $0.64, the stock is 22.35% and 73.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.09 million and changing -10.34% at the moment leaves the stock 11.14% off its SMA200. ENSC registered -25.66% loss for a year compared to 6-month loss of 0.90%. The firm has a 50-day simple moving average (SMA 50) of $0.36216 and a 200-day simple moving average (SMA200) of $0.576935.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 267.88% gain in the last 1 month and extending the period to 3 months gives it a 57.27%, and is -8.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.70% over the week and 28.30% over the month.
Ensysce Biosciences Inc (ENSC) has around 9 employees, a market worth around $12.45M and $4.42M in sales. Profit margin for the company is -179.29%. Distance from 52-week low is 350.21% and -69.14% from its 52-week high. The company has generated returns on investments over the last 12 months (-438.48%).
The EPS is expected to grow by 82.30% this year
14.0 institutions hold shares in Ensysce Biosciences Inc (ENSC), with institutional investors hold 22.53% of the company’s shares. The shares outstanding are 14.91M, and float is at 14.62M with Short Float at 43.47%. Institutions hold 22.26% of the Float.
The top institutional shareholder in the company is PLANTE MORAN FINANCIAL ADVISORS, LLC with over 20.0 shares valued at $10.0. The investor’s holdings represent 0.0004 of the ENSC Shares outstanding.
